Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A03956 | 33808045 | Cells | Computational Hypothesis: How Intra-Hepatic Functional Heterogeneity May Influence the Cascading Progression of Free Fatty Acid-Induced Non-Alcoholic Fatty Liver Disease (NAFLD). | 2021 | Details |
| A03957 | 33808036 | Biomolecules | Intracellular Toxic AGEs (TAGE) Triggers Numerous Types of Cell Damage. | 2021 | Details |
| A03958 | 33808007 | Int J Mol Sci | Momordica cochinchinensis Aril Ameliorates Diet-Induced Metabolic Dysfunction and Non-Alcoholic Fatty Liver by Modulating Gut Microbiota. | 2021 | Details |
| A03959 | 33807927 | Nutrients | Ginseng Saponin Enriched in Rh1 and Rg2 Ameliorates Nonalcoholic Fatty Liver Disease by Inhibiting Inflammasome Activation. | 2021 | Details |
| A03960 | 33807699 | J Clin Med | The Role of the Transsulfuration Pathway in Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A03961 | 33807672 | Cancers (Basel) | ARMCX3 Mediates Susceptibility to Hepatic Tumorigenesis Promoted by Dietary Lipotoxicity. | 2021 | Details |
| A03962 | 33807605 | Int J Mol Sci | Mechanisms by Which Probiotic Bacteria Attenuate the Risk of Hepatocellular Carcinoma. | 2021 | Details |
| A03963 | 33807573 | Int J Mol Sci | An Overview of the Molecular Mechanisms Contributing to Musculoskeletal Disorders in Chronic Liver Disease: Osteoporosis, Sarcopenia, and Osteoporotic Sarcopenia. | 2021 | Details |
| A03964 | 33807461 | Biomedicines | Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis-Roles as Putative Treatment Targets? | 2021 | Details |
| A03965 | 33807075 | J Pers Med | Gut Microbiota and Non-Alcoholic Fatty Liver Disease Severity in Type 2 Diabetes Patients. | 2021 | Details |
| A03966 | 33806955 | Biomedicines | Tanshinone IIA Downregulates Lipogenic Gene Expression and Attenuates Lipid Accumulation through the Modulation of LXRα/SREBP1 Pathway in HepG2 Cells. | 2021 | Details |
| A03967 | 33806784 | Children (Basel) | MAFLD in Obese Children: A Challenging Definition. | 2021 | Details |
| A03968 | 33806527 | Pharmaceuticals (Basel) | The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update. | 2021 | Details |
| A03969 | 33806428 | Cancers (Basel) | From Liver Fat to Cancer: Perils of the Western Diet. | 2021 | Details |
| A03970 | 33805912 | Int J Mol Sci | Potential of Nutraceutical Supplementation in the Modulation of White and Brown Fat Tissues in Obesity-Associated Disorders: Role of Inflammatory Signalling. | 2021 | Details |
| A03971 | 33805893 | J Clin Med | Risk of Liver Fibrosis According to TSH Levels in Euthyroid Subjects. | 2021 | Details |
| A03972 | 33805795 | Nutrients | The Role of Resveratrol in Liver Disease: A Comprehensive Review from In Vitro to Clinical Trials. | 2021 | Details |
| A03973 | 33804956 | J Clin Med | Role of Angiogenesis in the Pathogenesis of NAFLD. | 2021 | Details |
| A03974 | 33804819 | Antioxidants (Basel) | Reduced Liver Autophagy in High-Fat Diet Induced Liver Steatosis in New Zealand Obese Mice. | 2021 | Details |
| A03975 | 33804385 | J Pers Med | PNPLA3 and SERPINA1 Variants Are Associated with Severity of Fatty Liver Disease at First Referral to a Tertiary Center. | 2021 | Details |
| A03976 | 33804302 | J Clin Med | The Role of Diagnostic Biomarkers, Omics Strategies, and Single-Cell Sequencing for Nonalcoholic Fatty Liver Disease in Severely Obese Patients. | 2021 | Details |
| A03977 | 33804296 | J Clin Med | From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-New Terminology in Pediatric Patients as a Step in Good Scientific Direction? | 2021 | Details |
| A03978 | 33803718 | Int J Mol Sci | Till Death Do Us Part-The Multifaceted Role of Platelets in Liver Diseases. | 2021 | Details |
| A03979 | 33803038 | Int J Mol Sci | O-1602 Promotes Hepatic Steatosis through GPR55 and PI3 Kinase/Akt/SREBP-1c Signaling in Mice. | 2021 | Details |
| A03980 | 33803020 | Life (Basel) | Emerging Treatment Options for Sarcopenia in Chronic Liver Disease. | 2021 | Details |
| A03981 | 33802651 | Nutrients | Comparison of Ketogenic Diets with and without Ketone Salts versus a Low-Fat Diet: Liver Fat Responses in Overweight Adults. | 2021 | Details |
| A03982 | 33802455 | Nutrients | Fructo-Oligosaccharides and Pectins Enhance Beneficial Effects of Raspberry Polyphenols in Rats with Nonalcoholic Fatty Liver. | 2021 | Details |
| A03983 | 33802047 | J Clin Med | Natural History of NAFLD. | 2021 | Details |
| A03984 | 33801289 | Biomedicines | The Synergy between Organ-on-a-Chip and Artificial Intelligence for the Study of NAFLD: From Basic Science to Clinical Research. | 2021 | Details |
| A03985 | 33801028 | Int J Environ Res Public Health | Effect of Different Exercise Methods on Non-Alcoholic Fatty Liver Disease: A Meta-Analysis and Meta-Regression. | 2021 | Details |
| A03986 | 33801023 | Nutrients | Characterization of Gut Microbiome in Korean Patients with Metabolic Associated Fatty Liver Disease. | 2021 | Details |
| A03987 | 33800964 | Biology (Basel) | PNPLA3 Single Nucleotide Polymorphism Prevalence and Association with Liver Disease in a Diverse Cohort of Persons Living with HIV. | 2021 | Details |
| A03988 | 33800585 | Int J Environ Res Public Health | Quality of Life and Coping in Nonalcoholic Fatty Liver Disease: Influence of Diabetes and Obesity. | 2021 | Details |
| A03989 | 33800554 | Int J Mol Sci | The Role of CXCL16 in the Pathogenesis of Cancer and Other Diseases. | 2021 | Details |
| A03990 | 33800465 | Metabolites | Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03991 | 33799865 | Nutrients | A Positive Relationship between Betel Nut Chewing and Significant Liver Fibrosis in NAFLD Subjects, but Not in Non-NAFLD Ones. | 2021 | Details |
| A03992 | 33799862 | Int J Mol Sci | A Scoping Review on Lipocalin-2 and Its Role in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma. | 2021 | Details |
| A03993 | 33798787 | Cell Mol Gastroenterol Hepatol | Hypoxia via ERK Signaling Inhibits Hepatic PPARα to Promote Fatty Liver. | 2021 | Details |
| A03994 | 33798658 | Magn Reson Imaging | Effect of hepatic steatosis on native T1 mapping of 3T magnetic resonance imaging in the assessment of T1 values for patients with non-alcoholic fatty liver disease. | 2021 | Details |
| A03995 | 33798599 | Eur J Pharmacol | Effects of SGLT2 inhibitor ipragliflozin alone and combined with pioglitazone on fluid retention in type 2 diabetic mice with NASH. | 2021 | Details |
| A03997 | 33795579 | Eur J Gastroenterol Hepatol | Gut microbiota in nonalcoholic fatty liver diseases with and without type-2 diabetes mellitus. | 2021 | Details |
| A03998 | 33794916 | Nutr J | Low serum vitamin D concentrations are associated with obese but not lean NAFLD: a cross-sectional study. | 2021 | Details |
| A03999 | 33794784 | BMC Gastroenterol | A randomised placebo controlled trial of VSL#3® probiotic on biomarkers of cardiovascular risk and liver injury in non-alcoholic fatty liver disease. | 2021 | Details |
| A04000 | 33794741 | Autophagy | The ménage à trois of autophagy, lipid droplets and liver disease. | 2021 | Details |
| A04001 | 33794740 | Adipocyte | Swertiamarin supplementation prevents obesity-related chronic inflammation and insulin resistance in mice fed a high-fat diet. | 2021 | Details |
| A04002 | 33794385 | Eur J Med Chem | Design and synthesis of 1H-pyrazolo[3,4-b]pyridines targeting mitogen-activated protein kinase kinase 4 (MKK4) - A promising target for liver regeneration. | 2021 | Details |
| A04003 | 33793651 | PLoS One | Comparison between magnetic resonance and ultrasound-derived indicators of hepatic steatosis in a pooled NAFLD cohort. | 2021 | Details |
| A04004 | 33793621 | PLoS One | Assessment of the association between body composition and risk of non-alcoholic fatty liver. | 2021 | Details |
| A04005 | 33792864 | J Endocrinol Invest | Long non-coding RNAs in metabolic disorders: pathogenetic relevance and potential biomarkers and therapeutic targets. | 2021 | Details |
| A04006 | 33791907 | Mol Biol Rep | Bioactive dipeptide from potato protein hydrolysate combined with swimming exercise prevents high fat diet induced hepatocyte apoptosis by activating PI3K/Akt in SAMP8 mouse. | 2021 | Details |
| A04007 | 33791302 | Front Cell Dev Biol | Exploring the Causality Between Hypothyroidism and Non-alcoholic Fatty Liver: A Mendelian Randomization Study. | 2021 | Details |
| A04008 | 33790913 | Front Immunol | Group 3 Innate Lymphoid Cells Protect Steatohepatitis From High-Fat Diet Induced Toxicity. | 2021 | Details |
| A04009 | 33790601 | Diabetes Metab Syndr Obes | Identification of Hepatic Steatosis in Premenopausal and Postmenopausal Women Based on Phenotypes Combining Triglyceride Levels and Anthropometric Indices: A Cross-Sectional Study. | 2021 | Details |
| A04010 | 33790119 | Yakugaku Zasshi | [VNUT Is a Therapeutic Target for Type 2 Diabetes and NASH]. | 2021 | Details |
| A04011 | 33789906 | Sci Adv | Orally administered saccharide-sequestering nanocomplex to manage carbohydrate metabolism disorders. | 2021 | Details |
| A04012 | 33789150 | J Nutr Biochem | The transcription factors CREBH, PPARa, and FOXO1 as critical hepatic mediators of diet-induced metabolic dysregulation. | 2021 | Details |
| A04013 | 33788613 | Environ Health Perspect | Effect of Epidermal Growth Factor Treatment and Polychlorinated Biphenyl Exposure in a Dietary-Exposure Mouse Model of Steatohepatitis. | 2021 | Details |
| A04014 | 33788569 | J Nat Prod | Diverse Polycyclic Polyprenylated Acylphloroglucinol Congeners with Anti-Nonalcoholic Steatohepatitis Activity from Hypericum forrestii. | 2021 | Details |
| A04016 | 33788377 | Liver Int | Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non-alcoholic steatohepatitis. | 2021 | Details |
| A04017 | 33788206 | Semin Liver Dis | Wearables, Physical Activity, and Exercise Testing in Liver Disease. | 2021 | Details |
| A04018 | 33788095 | Dig Dis Sci | Visceral Adipose Tissue and Non-alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes. | 2021 | Details |
| A04019 | 33787507 | Dis Model Mech | Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver. | 2021 | Details |
| A04020 | 33787249 | J Agric Food Chem | Malvidin-3-O-Glucoside from Blueberry Ameliorates Nonalcoholic Fatty Liver Disease by Regulating Transcription Factor EB-Mediated Lysosomal Function and Activating the Nrf2/ARE Signaling Pathway. | 2021 | Details |
| A04021 | 33787044 | Asia Pac J Clin Nutr | Dietary n-3 and n-6 fatty acid intakes and NAFLD: A cross-sectional study in the United States. | 2021 | Details |
| A04023 | 33785637 | Pediatrics | Alternative Etiologies of Liver Disease in Children With Suspected NAFLD. | 2021 | Details |
| A04025 | 33785339 | Life Sci | A rapid juvenile murine model of nonalcoholic steatohepatitis (NASH): Chronic intermittent hypoxia exacerbates Western diet-induced NASH. | 2021 | Details |
| A04026 | 33785162 | Methods Cell Biol | Diethylnitrosamine-induced liver tumorigenesis in mice. | 2020 | Details |
| A04027 | 33785040 | J Biomed Sci | HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients. | 2021 | Details |
| A04028 | 33785007 | BMC Complement Med Ther | Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male albino wistar rats. | 2021 | Details |
| A04029 | 33784797 | Phytother Res | Isotschimgine alleviates nonalcoholic steatohepatitis and fibrosis via FXR agonism in mice. | 2021 | Details |
| A04030 | 33783746 | Adv Exp Med Biol | Prevention of NAFLD/NASH by Astaxanthin and β-Cryptoxanthin. | 2021 | Details |
| A04031 | 33783745 | Adv Exp Med Biol | Molecular Mechanisms of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH). | 2021 | Details |
| A04032 | 33782980 | Andrologia | Nonalcoholic fatty liver disease and risk of prostatic diseases: Roles of insulin resistance. | 2021 | Details |
| A04033 | 33782808 | Dig Dis Sci | Fatty Liver Index and Development of Cardiovascular Disease: Findings from the UK Biobank. | 2021 | Details |
| A04034 | 33782517 | Sci Rep | Non-alcoholic fatty liver disease in polycystic ovary syndrome women. | 2021 | Details |
| A04035 | 33780962 | Obes Facts | Triglycerides Mediate Body Mass Index and Nonalcoholic Fatty Liver Disease: A Population-Based Study. | 2021 | Details |
| A04036 | 33780554 | Transpl Int | Portal vein thrombosis and renal dysfunction: a national comparative study of liver transplant recipients for NAFLD versus alcoholic cirrhosis. | 2021 | Details |
| A04037 | 33780425 | MEDICC Rev | Non-Alcoholic Fatty Liver Disease in Cuba. | 2021 | Details |
| A04038 | 33780219 | J Clin Gastroenterol | Identifying Advanced Fibrosis in NAFLD Using Noninvasive Tests: A Systematic Review of Sequential Algorithms. | 2022 | Details |
| A04039 | 33780129 | Am J Transplant | Sleeve gastrectomy prior to liver transplantation is superior to medical weight loss in reducing posttransplant metabolic complications. | 2021 | Details |
| A04040 | 33779880 | Dig Dis Sci | Progression of Nonalcoholic Fatty Liver Disease-Associated Fibrosis in a Large Cohort of Patients with Type 2 Diabetes. | 2021 | Details |
| A04041 | 33779332 | Hum Exp Toxicol | Therapeutic effects of myocardin-related transcription factor A (MRTF-A) knockout on experimental mice with nonalcoholic steatohepatitis induced by high-fat diet. | 2021 | Details |
| A04042 | 33777980 | Front Med (Lausanne) | Dynamic Chronological Changes in Serum Triglycerides Are Associated With the Time Point for Non-alcoholic Fatty Liver Disease Development in the Nationwide Korean Population Cohort. | 2021 | Details |
| A04043 | 33777974 | Front Med (Lausanne) | Metabolic Associated Fatty Liver Disease Is Associated With an Increased Risk of Severe COVID-19: A Systematic Review With Meta-Analysis. | 2021 | Details |
| A04044 | 33777700 | Toxicol Rep | Polychlorinated biphenyls altered gut microbiome in CAR and PXR knockout mice exhibiting toxicant-associated steatohepatitis. | 2021 | Details |
| A04045 | 33777674 | Acta Pharm Sin B | S-Allylmercaptocysteine improves alcoholic liver disease partly through a direct modulation of insulin receptor signaling. | 2020 | Details |
| A04046 | 33777158 | Evid Based Complement Alternat Med | Hepatocardiac or Cardiohepatic Interaction: From Traditional Chinese Medicine to Western Medicine. | 2021 | Details |
| A04047 | 33776934 | Front Endocrinol (Lausanne) | The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort Study. | 2021 | Details |
| A04048 | 33776901 | Front Endocrinol (Lausanne) | Dietary Oxysterol, 7-Ketocholesterol Accelerates Hepatic Lipid Accumulation and Macrophage Infiltration in Obese Mice. | 2021 | Details |
| A04049 | 33776490 | J Exp Pharmacol | Experimental and Investigational Targeted Therapies for the Management of Fibrosis in NASH: An Update. | 2021 | Details |
| A04050 | 33776471 | Int J Gen Med | The Diabetes Syndrome - A Collection of Conditions with Common, Interrelated Pathophysiologic Mechanisms. | 2021 | Details |
| A04051 | 33776366 | World J Gastroenterol | Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease. | 2021 | Details |
| A04052 | 33775894 | Clin Gastroenterol Hepatol | Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study. | 2021 | Details |
| A04053 | 33775782 | Food Chem Toxicol | Investigation of steatosis profiles induced by pesticides using liver organ-on-chip model and omics analysis. | 2021 | Details |
| A04054 | 33775752 | Virus Res | The identify role and molecular mechanism of the MALAT1/hsa-mir-20b-5p/TXNIP axis in liver inflammation caused by CHB in patients with chronic HBV infection complicated with NAFLD. | 2021 | Details |
| A04055 | 33774058 | J Hepatol | Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD. | 2021 | Details |
| A04056 | 33773953 | Redox Biol | Impact of vitamin E on redox biomarkers in non-alcoholic fatty liver disease. | 2021 | Details |
| A04057 | 33773856 | Rev Gastroenterol Mex (Engl Ed) | Fibrosis assessment in patients with nonalcoholic fatty liver disease: Adherence to proposed algorithms and barriers to complying with them. | 2021 | Details |
| A04058 | 33773656 | Food Res Int | Dietary anthocyanins as potential natural modulators for the prevention and treatment of non-alcoholic fatty liver disease: A comprehensive review. | 2021 | Details |
| A04059 | 33773468 | Biomed Pharmacother | 4-Acetylantroquinonol B ameliorates nonalcoholic steatohepatitis by suppression of ER stress and NLRP3 inflammasome activation. | 2021 | Details |